文献速递乳腺癌

血浆磷脂脂肪酸与乳腺癌风险的前瞻性评估:EPIC研究

A prospective evaluation of plasma phospholipid fatty acids and breast cancer risk in the EPIC study.
PubMed 文献 · Ann Oncol · 2017-01-01

在欧洲癌症与营养前瞻性调查(EPIC)队列内嵌套的病例对照研究中,采用气相色谱检测2982例乳腺癌病例与2982例匹配对照的诊断前血浆磷脂脂肪酸。棕榈油酸最高四分位组与最低四分位组相比乳腺癌风险升高(OR 1.37),工业反式脂肪酸与ER阴性肿瘤风险升高相关(OR 2.01)。n-3多不饱和脂肪酸与乳腺癌风险无显著关联。

要点

  • 棕榈油酸最高四分位组与最低四分位组相比,乳腺癌风险升高(OR 1.37,95%CI 1.14-1.64)。
  • 工业反式脂肪酸最高三分位组与最低三分位组相比,ER阴性肿瘤风险升高(OR 2.01,95%CI 1.03-3.90)。
  • n-3多不饱和脂肪酸与乳腺癌风险总体及按激素受体分层均无显著关联。

核心结论

  • 研究结果提示,以棕榈油酸合成增加为表现的从头脂肪生成增强,可能是乳腺癌发生的相关代谢途径。
  • 工业加工来源的膳食反式脂肪酸可能特异性增加ER阴性乳腺癌风险。
  • n-3多不饱和脂肪酸与乳腺癌风险总体及按激素受体分层均无显著关联。

研究设计与样本

  • 在欧洲癌症与营养前瞻性调查(EPIC)队列内嵌套的病例对照研究。
  • 采用气相色谱法在诊断前血浆磷脂中检测60种脂肪酸。
  • 2982例新发乳腺癌病例与2982例对照进行匹配。
  • 采用条件logistic回归模型估计脂肪酸水平与乳腺癌风险的相对危险度。
  • 计算错误发现率(q值)以控制多重比较。

主要发现

  • 棕榈油酸最高四分位组与最低四分位组相比,乳腺癌风险升高(OR 1.37;95%CI 1.14-1.64;趋势P=0.0001,q值=0.004)。
  • 去饱和指数DI16(16:1n-7/16:0)最高四分位组与最低四分位组相比,乳腺癌风险升高(OR 1.28;95%CI 1.07-1.54;趋势P=0.002,q值=0.037)。
  • 工业反式脂肪酸最高三分位组与最低三分位组相比,ER阴性肿瘤风险升高(OR 2.01;95%CI 1.03-3.90;趋势P=0.047),ER阳性肿瘤未见关联(异质性P=0.01)。
  • n-3多不饱和脂肪酸与乳腺癌风险总体及按激素受体分层均无显著关联。

关键数值与推荐

  • 棕榈油酸以最高四分位组与最低四分位组比较:OR 1.37;95%CI 1.14-1.64;趋势P=0.0001,q值=0.004。
  • 去饱和指数DI16(16:1n-7/16:0)以最高四分位组与最低四分位组比较:OR 1.28;95%CI 1.07-1.54;趋势P=0.002,q值=0.037。
  • 工业反式脂肪酸以最高三分位组与最低三分位组比较:ER阴性肿瘤OR 2.01;95%CI 1.03-3.90;趋势P=0.047;ER阳性肿瘤未见关联(异质性P=0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intakes of specific fatty acids have been postulated to impact breast cancer risk but epidemiological data based on dietary questionnaires remain conflicting. MATERIALS AND METHODS: We assessed the association between plasma phospholipid fatty acids and breast cancer risk in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition study. Sixty fatty acids were measured by gas chromatography in pre-diagnostic plasma phospholipids from 2982 incident breast cancer cases matched to 2982 controls. Conditional logistic regression models were used to estimate relative risk of breast cancer by fatty acid level. The false discovery rate (q values) was computed to control for multiple comparisons. Subgroup analyses were carried out by estrogen receptor (ER) and progesterone receptor expression in the tumours. RESULTS: A high level of palmitoleic acid [odds ratio (OR) for the highest quartile compared with the lowest OR (Q4-Q1) 1.37; 95% confidence interval (CI), 1.14-1.64; P for trend = 0.0001, q value = 0.004] as well as a high desaturation index (DI16) (16:1n-7/16:0) [OR (Q4-Q1), 1.28; 95% C, 1.07-1.54; P for trend = 0.002, q value = 0.037], as biomarkers of de novo lipogenesis, were significantly associated with increased risk of breast cancer. Levels of industrial trans-fatty acids were positively associated with ER-negative tumours [OR for the highest tertile compared with the lowest (T3-T1)=2.01; 95% CI, 1.03-3.90; P for trend = 0.047], whereas no association was found for ER-positive tumours (P-heterogeneity =0.01). No significant association was found between n-3 polyunsaturated fatty acids and breast cancer risk, overall or by hormonal receptor. CONCLUSION: These findings suggest that increased de novo lipogenesis, acting through increased synthesis of palmitoleic acid, could be a relevant metabolic pathway for breast tumourigenesis. Dietary trans-fatty acids derived from industrial processes may specifically increase ER-negative breast cancer risk.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Chajès V, Assi N, Biessy C, et al. A prospective evaluation of plasma phospholipid fatty acids and breast cancer risk in the EPIC study. Ann Oncol. 2017. PMID: 28950350. doi:10.1093/annonc/mdx482

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。